Information Library
Enrollment & retention - High-quality studies - Patient & Investigator Recruitment
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
Accelerated Access
June 2, 2010
Quintiles drew on extensive experience, a thorough understanding of the disease state and a myriad of tools in the Quintiles recruitment arsenal for a comprehensive solution to reach the right patients at the right time. -
QUINTILES AND KAISER PERMANENTE ANNOUNCE ALLIANCE TO ACCELERATE DRUG DEVELOPMENT
May 18, 2010 - Quintiles is accelerating drug development with the addition of Kaiser Permanente's Southern California Permanente Medical Group to its global site program
-
Enrollment Target Acheived Early for Ulcerative Colitis Study
January 19, 2010
Although faced with the challenge of recruiting for this small patient population, enrollment was completed two months ahead of schedule. -
Tight Turnaround for H1N1 Vaccine
December 3, 2009
Despite short timelines and government requirements, an H1N1 vaccine study finished in time for the 2009 influenza season. -
Overcoming Off-Season Recruiting Challenges
December 3, 2009
How do you recruit for an influenza vaccine trial off-season? Quintiles tapped our Partner Sites and completed enrollment in just four days. -
QUINTILES ANNOUNCES NEW GHANA OFFICE
June 16, 2009 - To improve efficiency and expand capacity to monitor the growing number of clinical studies being conducted in Western Sub-Saharan Africa, Quintiles today announced the opening of a new office in Accra, Ghana.
Page 1 of 1 (6 results)
